Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma

Haematologica

Volumn 82, Issue 1, 1997, Pages 38-42

  Faggioli, Paola ^a   De Paschale, Massimo ^a   Tocci, Antonio ^a   Luoni, Marco ^a   Fava, Sergio ^a   De Paoli, Alberto ^a   Tosi, Anna ^a   Cassi, Edmondo ^a  

^a Ospedale di Legnano   (Italy)

Author keywords

Drug related hepatotoxicity; Hepatitis (B C) reactivation; Lymphoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FOLINIC ACID; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINCRISTINE; VINCRISTINE SULFATE; VIRUS DNA;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CLINICAL TRIAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; VIRUS REACTIVATION; VIRUS REPLICATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS, TOXIC; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LYMPHOMA, B-CELL; MALE; METHOTREXATE; MIDDLE AGED; MITOXANTRONE; POLYMERASE CHAIN REACTION; PREDNISOLONE; PREDNISONE; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; VINCRISTINE; VIREMIA; VIRUS ACTIVATION;

EID: 0031451377     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Perry MC. Hepatotoxicity of chemotherapeutic agents. Semin Oncol 1982; 9:65-74.
2. Arai N, Kaneko H, Umeda M, Tsukahara T, Shirai T. Non-Hodgkin's lymphoma in an elderly patient complicated by cyclophosphamide-induced allergic hepatic dysfunction. Nippon Ronen Igakkai Zasshi 1992;29:681-5.
3. Aubrey DA. Massive hepatic necrosis after cyclophosphamide. Br Med J 1970; 3:588.
4. Liang RHS, Lok ASF, Lai CL, Chan TK, Todd D, Chin EKW. Hepatitis B infection in patients with lymphomas. Hematol Oncol 1990; 8:261-70.
5. Cavanna L, Sballi G, Tanzi E, et al. High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders. Haematologica 1995; 89:486-7.
6. Ferri C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88:392-4.
7. Luppi M, Longo G, Ferrari MG, et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996; 10:373-5.
8. Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994; 20:1442-9.
9. Luppi M, Torelli G. The new lymphotropic herpes viruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview. Haematologica 1996; 81:265-81.
10. Musolino C, Campo S, Pollicino T, Squadrito G, Spatari G, Raimondo G. Evaluation of hepatitis B ad C virus infections in patients with non-Hodgkin's lymphoma and without liver disease. Haematologica 1996; 81:162-4.
11. Silvestri F, Pipan C, Barillari G, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 10:4296-301.
12. Lok ASF, Liang RHS, Chin EKW, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100:182-8.
13. Soh LT, Ang PT, Sng I, Chua EJ, Ong YW. Fulminant hepatic failure in non-Hodgkin lymphoma patients treated with chemotherapy. Eur J Cancer 1992; 28:1338-9.
14. Gruber A, Lundberg LG, Bjorkholm M. Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy. J Int Med 1983; 234:223-5.
15. Kunamori H, Fukawa H, Maruta A, et al. Case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantation. Am J Med Sci 1992; 303:109-11.
16. Fan FS, Tzeng CH, Hsiao KI, Hu ST, Lin WT, Chen PM. Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transpl 1991; 8:417-20.
17. Kodama F, Noguchi T, Ogawa K, et al. Clinical investigation of the chemotherapy to malignant lymphoma patients with hepatitis virus. T 14 Abstracts-Fifth International Conference on Malignant Lymphoma, Lugano, June 9-12, 1993.
18. Tanosaki R, Okamoto S, Akatsuka N, et al. Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone, using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphoma. Cancer 1994; 74:1939-44.
19. Faggioli P, Casiraghi A, De Paoli A, et al. Tossicità epatica acuta in corso di polichemioterapia ciclica nelle malattie onco-ematologiche. Argomenti di Oncologia 1996; 17:221-31.
20. Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347:92-3.
21. Yoshiba M, Sekiyama K, Sugata F, et al. Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci 1992; 37:1253-9.
22. nd ed. New York:Springer Verlag, 1992.
23. Bernasconi C, Lazzarino M, Brusamolino E. Nuovi chemioterapici in oncoematologia. Progressi in Ematologia Clinica 1987; 6:221-37.
24. Lambertenghi-Deliliers G, Butti C, Baldini L, et al. A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma. Haematologica 1995; 80:318-24.
25. Cassi E, Butti C, Baldini L, et al. A cooperative study on ProMACE-CytaBOM in aggressive non-Hodgkin's lymphomas. Leuk Lymphoma 1994; 13:111-8.
26. Kroes ACM, De Man RA, Niesters HGM, et al. Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only. J Hepatol 1994; 21:1113-5.
27. Wands JR. Subacute and chronic active hepatitis after withdrawal of chemotherapy. Lancet 1975; 2:979.
28. Onvubalili JK. Fulminant hepatic failure in nephrotic syndrome related to withdrawal of immunosuppressive therapy. Postgrad Med J 1988; 64:325-7.